KALA BIO, Inc. Share Price & Technical Analysis
KALA · $2.23 (-8.23%)
Healthcare / Biotechnology
$2.23
-8.23%
KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical de…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-56% return in May, -3% avg return in past 3 year May month.
-183% return in 2026, -58% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -5% | -25% | -55% | -42% | -56% | – | – | – | – | – | – | – | -183% |
| 25 | 24% | -24% | -20% | -32% | -3% | 29% | 44% | 71% | -87% | -47% | 21% | -57% | -82% |
| 24 | -1% | 3% | 6% | -15% | 2% | 1% | -8% | -9% | -3% | 24% | -2% | 2% | 1% |
| 23 | -46% | -41% | 50% | 7% | -7% | 2% | 2% | -10% | -33% | -23% | -13% | 20% | -93% |
| 22 | -28% | -25% | 99% | -51% | -50% | -21% | 10% | -8% | -22% | -43% | -17% | 618% | 462% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$53.63M
P/E ratio
—
52W high
$1,030
52W low
$2.22
Volume
62,922
Beta
-2.24
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is KALA BIO, Inc. share price today?
- KALA BIO, Inc. (KALA) last traded around $2.23 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does KALA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for KALA. Download the app for real-time alerts.
- How can I analyze KALA BIO, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.